Stages of non small cell lung cancer (NSCLC) Staging of lung cancer is an important process and the stage of the cancer is determined to through tests performed at the time of diagnosis. The stage of cancer can also give out information of how big the tumor is and how far the the cance...
The researchers, in tests on cells in the lab, have found that a class of nanoparticles known as polyamidoamine dendrimers (PAMAMs) cause lung damage that can lead to lung cancer by triggering a type of programmed death cell known as autophagic cell death....
Stages of non small cell lung cancer (NSCLC) Staging of lung cancer is an important process and the stage of the cancer is determined to through tests performed at the time of diagnosis. The stage of cancer can also give out information of how big the tumor is and how far the the cance...
Similar diagnostic yields were observed using progressively increasing or progressively decreasing changes of the marker level. In lung cancer, the diagnosis (and even the anticipation) of disease status is often possible using appropriate threshold value of TPA....
This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the ...
Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014;94:107–16. 24. Gao Q, Wang XY, Qiu SJ, et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res. 2009;...
Single-cell Lung Cancer Atlas with 1.2M cells. Contribute to icbi-lab/luca development by creating an account on GitHub.
Lung cancer is the leading cause of cancer-associated mortality worldwide1. Here we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACERx s
This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the ...
existence among these cells of a rare cell type (stained blue-green), believed to be a tuft cell. Researchers have discovered a new type of lung cancer with origins in these cells, which overexpress a gene-regulating protein called POU2F3, a potential target for therapyCREDIT: Vakoc Lab, ...